- 专利标题： Aminopyrazine derivatives as PI3K-γ inhibitors
-
申请号： US16458530申请日： 2019-07-01
-
公开(公告)号： US11046658B2公开(公告)日： 2021-06-29
- 发明人: Brent Douty , Yanran Ai , David M. Burns , Andrew P. Combs , Nikoo Falahatpisheh , Daniel Levy , Padmaja Polam , Lixin Shao , Stacey Shepard , Artem Shvartsbart , Eddy W. Yue , Andrew W. Buesking
- 申请人： Incyte Corporation
- 申请人地址： US DE Wilmington
- 专利权人： Incyte Corporation
- 当前专利权人： Incyte Corporation
- 当前专利权人地址： US DE Wilmington
- 代理机构： Fish & Richardson P.C.
- 主分类号： C07D241/20
- IPC分类号： C07D241/20 ; C07D401/04 ; C07D401/14 ; C07D403/04 ; C07D403/06 ; C07D403/12 ; C07D403/14 ; C07D405/12 ; C07D413/04 ; C07D417/04 ; C07D471/04 ; C07D471/06 ; C07D487/04
摘要：
This application relates to compounds of Formula (I): or pharmaceutically acceptable salts thereof, which are inhibitors of PI3K-γ which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.
公开/授权文献
- US20200002295A1 AMINOPYRAZINE DERIVATIVES AS PI3K-y INHIBITORS 公开/授权日：2020-01-02
信息查询
